Quintet Private Bank (Europe)’s VanEck Biotech ETF BBH Stock Holding History

Quintet Private Bank (Europe)’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,452	Closed	-$662K	–	228
2024 Q1	$662K	Buy	+3,452	New	+$572K	0.03%	99
2023 Q3	–	Sell	-3,990	Closed	-$622K	–	258
2023 Q2	$622K	Sell	3,990 -14	-0.3%	-$2.24K	0.03%	94
2023 Q1	$648K	Buy	+4,004	New	+$648K	0.04%	94
2022 Q2	$622K	Buy	+3,990	New	+$594K	0.03%	94

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Quintet Private Bank (Europe)'s BBH Position: Q2 2024 in Review

Quintet Private Bank (Europe) sold out of VanEck Biotech ETF (BBH) in Q2 2024, closing a stake of 3,452 shares — an estimated $662K sold.

Quintet Private Bank (Europe) first reported a position in BBH in Q2 2022 and held it in 4 quarters. The position peaked at $662K in Q1 2024. 116 funds tracked by Wall St. Rank hold BBH as of Q2 2024.

Quintet Private Bank (Europe) reported no remaining VanEck Biotech ETF position as of Q2 2024 after selling out during the quarter.
Quintet Private Bank (Europe) sold 3,452 VanEck Biotech ETF shares in Q2 2024, an estimated $662K.
Quintet Private Bank (Europe) first reported a position in VanEck Biotech ETF in Q2 2022 and held it in 4 quarters.
Quintet Private Bank (Europe)'s VanEck Biotech ETF position peaked at $662K in Q1 2024.
116 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2024.

Based on Quintet Private Bank (Europe)'s 13F filing for Q2 2024, filed 24 Jul 2024.